ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Incyte Corporation

Incyte Corporation (INCY)

67,28
-1,18
( -1,72% )

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
67,28
Gebot
67,27
Fragen
67,30
Volumen
673.943
66,7401 Tagesbereich 68,78
53,56 52-Wochen-Bereich 83,95
Marktkapitalisierung
Handelsende
68,46
Handelsbeginn
68,10
Letzte Trade
12
@
67.3048
Letzter Handelszeitpunkt
20:48:28
Finanzvolumen
US$ 45.681.754
VWAP
67,7828
Durchschnittliches Volumen (3 Mio.)
2.048.305
Ausgegebene Aktien
193.569.934
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
399,41
Gewinn pro Aktie (EPS)
0,17
Erlöse
4,24B
Nettogewinn
32,62M

Über Incyte Corporation

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly)... Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs. Mehr anzeigen

Sektor
Coml Physical, Biologcl Resh
Branche
Coml Physical, Biologcl Resh
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Incyte Corporation is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker INCY. The last closing price for Incyte was US$68,46. Over the last year, Incyte shares have traded in a share price range of US$ 53,56 to US$ 83,95.

Incyte currently has 193.569.934 shares in issue. The market capitalisation of Incyte is US$13,25 billion. Incyte has a price to earnings ratio (PE ratio) of 399.41.

Option-Flow Incyte (INCY)

Gesamtfluss

Bullisch

Nettoprämie

54k

Calls / Puts

100,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

0,00%

INCY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-3.52-4.9717514124370.871.2966.7401233462969.45757057CS
42.333.5873749037764.9571.2963.925216575067.8074543CS
127.1311.853699085660.1571.2953.56204830562.81035819CS
26-1.3-1.8955963837968.5876.9253.56187005365.71611452CS
523.916.170112040463.3783.9553.56200530166.66056346CS
156-6.91-9.3139237093974.1986.2950.27191176665.82884143CS
260-42.18-38.5346245204109.46111.0550.27171582070.30431403CS

INCY - Frequently Asked Questions (FAQ)

What is the current Incyte share price?
The current share price of Incyte is US$ 67,28
How many Incyte shares are in issue?
Incyte has 193.569.934 shares in issue
What is the market cap of Incyte?
The market capitalisation of Incyte is USD 13,25B
What is the 1 year trading range for Incyte share price?
Incyte has traded in the range of US$ 53,56 to US$ 83,95 during the past year
What is the PE ratio of Incyte?
The price to earnings ratio of Incyte is 399,41
What is the cash to sales ratio of Incyte?
The cash to sales ratio of Incyte is 3,07
What is the reporting currency for Incyte?
Incyte reports financial results in USD
What is the latest annual turnover for Incyte?
The latest annual turnover of Incyte is USD 4,24B
What is the latest annual profit for Incyte?
The latest annual profit of Incyte is USD 32,62M
What is the registered address of Incyte?
The registered address for Incyte is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Incyte website address?
The website address for Incyte is www.incyte.com
Which industry sector does Incyte operate in?
Incyte operates in the COML PHYSICAL, BIOLOGCL RESH sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MAASMaase Inc
US$ 9,72
(260,00%)
44,14k
CDTXCidara Therapeutics Inc
US$ 42,8972
(104,08%)
5,75M
INDPIndaptus Therapeutics Inc
US$ 0,5157
(90,93%)
348,02M
SHOTWSafety Shot Inc
US$ 0,032
(87,13%)
13,79k
GEOSGeospace Technologies Corporation
US$ 17,61
(53,26%)
2,69M
HIMZDefiance Daily Target 2X Long HIMS ETF
US$ 18,72
(-63,03%)
15,85M
SANWS and W Seed Company
US$ 2,3894
(-55,42%)
814,68k
CMPSCOMPASS Pathways PLC
US$ 2,3501
(-49,24%)
31,54M
RGCRegencell Bioscience Holdings Ltd
US$ 21,7183
(-42,86%)
1,54M
NXTTNext Technology Holding Inc
US$ 2,2701
(-34,01%)
2,34M
HCTIHealthcare Triangle Inc
US$ 0,029205
(-2,65%)
500M
CGBSCrown LNG Holdings Ltd
US$ 0,1121
(21,32%)
374,94M
INDPIndaptus Therapeutics Inc
US$ 0,5157
(90,93%)
348,03M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 14,635
(18,41%)
320,63M
GNLNGreenlane Holdings Inc
US$ 0,0089
(2,30%)
224,42M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock